JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kjeldsen, T.
Right arrow Articles by Andersen, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kjeldsen, T.
Right arrow Articles by Andersen, A. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 269, Issue 52, 32942-32946, Dec, 1994

Chimeric receptors indicate that phenylalanine 39 is a major contributor to insulin specificity of the insulin receptor

T Kjeldsen, FC Wiberg and AS Andersen
Novo Nordisk A/S, Bagsvaerd, Denmark.

The exact nature of how the insulin molecule interacts with the insulin receptor is obscure although chimeric receptors have shown that the ligand specificity of the insulin receptor and the IGF-I receptor (i.e. the sequences that discriminate between insulin and insulin-like growth factor I) reside in different regions of a common binding site and that the N-terminal 68 amino acids of the insulin receptor are involved in conferring specificity for insulin on this receptor (Kjeldsen, T., Andersen, A. S., Wiberg, F. C., Rasmussen, J. S., Schaffer, L., Balschmidt, P., Moller, K. B., and Moller, N. P. H. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 4404-4408). Using chimeric insulin/IGF-I receptors to elucidate how the insulin receptor interacts with the insulin molecule we identified phenylalanine 39 of the insulin receptor as a major contributor in determining the receptor specificity for insulin, increasing insulin affinity 15-fold when replacing the corresponding amino acid in the insulin-like growth factor I receptor. Furthermore, replacement of the insulin receptor amino acid phenylalanine 39 with the corresponding IGF-I receptor amino acid, serine 35, decreased insulin affinity 8-fold.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Suh, G. Atzmon, M.-O. Cho, D. Hwang, B. Liu, D. J. Leahy, N. Barzilai, and P. Cohen
Functionally significant insulin-like growth factor I receptor mutations in centenarians
PNAS, March 4, 2008; 105(9): 3438 - 3442.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. H. Surinya, B. E. Forbes, F. Occhiodoro, G. W. Booker, G. L. Francis, K. Siddle, J. C. Wallace, and L. J. Cosgrove
An Investigation of the Ligand Binding Properties and Negative Cooperativity of Soluble Insulin-like Growth Factor Receptors
J. Biol. Chem., February 29, 2008; 283(9): 5355 - 5363.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Lou, T. P. J. Garrett, N. M. McKern, P. A. Hoyne, V. C. Epa, J. D. Bentley, G. O. Lovrecz, L. J. Cosgrove, M. J. Frenkel, and C. W. Ward
The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity
PNAS, August 15, 2006; 103(33): 12429 - 12434.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. H. Surinya, L. Molina, M. A. Soos, J. Brandt, C. Kristensen, and K. Siddle
Role of Insulin Receptor Dimerization Domains in Ligand Binding, Cooperativity, and Modulation by Anti-receptor Antibodies
J. Biol. Chem., May 3, 2002; 277(19): 16718 - 16725.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Whittaker, A. V. Groth, D. C. Mynarcik, L. Pluzek, V. L. Gadsboll, and L. J. Whittaker
Alanine Scanning Mutagenesis of a Type 1 Insulin-like Growth Factor Receptor Ligand Binding Site
J. Biol. Chem., November 16, 2001; 276(47): 43980 - 43986.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
C W Ward, T P J Garrett, N M McKern, M Lou, L J Cosgrove, L G Sparrow, M J Frenkel, P A Hoyne, T C Elleman, T E Adams, et al.
The three dimensional structure of the type I insulin-like growth factor receptor
Mol. Pathol., June 1, 2001; 54(3): 125 - 132.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Rouard, J. Bass, F. Grigorescu, T. P. J. Garrett, C. W. Ward, G. Lipkind, C. Jaffiole, D. F. Steiner, and G. I. Bell
Congenital Insulin Resistance Associated with a Conformational Alteration in a Conserved beta -Sheet in the Insulin Receptor L1 Domain
J. Biol. Chem., June 25, 1999; 274(26): 18487 - 18491.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Bass, T. Kurose, M. Pashmforoush, and D. F. Steiner
Fusion of Insulin Receptor Ectodomains to Immunoglobulin Constant Domains Reproduces High-affinity Insulin Binding in Vitro
J. Biol. Chem., August 9, 1996; 271(32): 19367 - 19375.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1994 by the American Society for Biochemistry and Molecular Biology.